BioProcess International Europe is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


A. Krishna Prasad, Ph.D.
Founder at Citranvi, LLC.


Dr. Krishna Prasad, the founder of Citranvi™, is a recognized industry leader in Vaccine Development. Prior to this, Dr. Prasad functioned as the Director of Vaccine Research and Development, at Pfizer.  He spent 20 years at Wyeth/Pfizer, he successfully led many innovative and complex multi-component vaccine candidates through all stages of pre-clinical and clinical development through commercial licensure.  This includes Pneumococcal conjugate vaccine Prevnar-13® and many clinical candidates. He has been named as an inventor or co-inventor in more than 150 granted patents, world-wide, which played a significant role towards the development and protection of Pfizer’s diverse conjugate vaccine intellectual property portfolio.

A. Krishna Prasad, Ph.D.'s Network

Agenda Sessions

  • Challenges in Multicomponent Vaccine Development and Manufacturing

  • Chairperson's Opening Remarks


Speakers at this event